GlassScriptPhysician profile
Colette Dipierro
NPI 1700072386
$5,029.49
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,081 · 2022: $1,181 · 2023: $2,124 · 2024: $643.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,587 · Education: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,586.98 |
| Education | $179.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $606.73 | 2021-2024 | |
| Amgen INC. | $533.79 | 2021-2023 | Otezla |
| Pfizer INC. | $477.16 | 2021-2024 | |
| Janssen Biotech, INC. | $424.49 | 2021-2024 | Tremfya |
| E.R. Squibb & Sons, L.L.C. | $422.37 | 2022-2024 | Sotyktu |
| Galderma Laboratories, L.P. | $332.73 | 2022-2023 | Oracea, Epsolay, Aklief |
| Dermavant Sciences, INC. | $297.05 | 2022-2024 | Vtama |
| Sun Pharmaceutical Industries INC. | $233.29 | 2021-2023 | Winlevi, Absorica Ld |
| Arcutis Biotherapeutics, INC. | $231.46 | 2023-2024 | Zoryve |
| Genzyme Corporation | $226.05 | 2021-2024 | |
| Lilly USA, LLC | $215.43 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $207.89 | 2023-2024 | |
| Incyte Corporation | $125.27 | 2022-2024 | Opzelura |
| Almirall LLC | $93.32 | 2021-2024 | Seysara, Klisyri |
| Mayne Pharma Commercial LLC | $92.37 | 2021-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $88.89 | 2021-2023 | Adbry |
| Merz North America, INC. | $84.89 | 2021-2023 | Xeomin |
| Ucb, INC. | $65.56 | 2022-2023 | Cimzia |
| Regeneron Healthcare Solutions, INC. | $62.21 | 2021-2024 | Dupixent |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $58.98 | 2021-2022 | |
| Epi Health, LLC | $50.00 | 2021 | |
| Journey Medical Corporation | $28.99 | 2022 | |
| Vyne Pharmaceuticals INC. | $21.50 | 2021 | |
| Strata Skin Sciences, INC. | $20.00 | 2023 | Xtrac |
| Dermira, INC. | $15.45 | 2021 | |
| Mission Pharmacal Company | $13.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colette Dipierro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.